ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2728

Validation of the Draft Classification Criteria of Granulomatosis with Polyangiitis (GPA) Amongst Indian Patients with ANCA Associated Vasculitis

Aman Sharma1, Adarsh MB2, GSRSNK Naidu3, Manish Rathi4, Kusum Sharma5, Varun Dhir6, Ritambhra Nada7, Ranjana Minz8 and Sanjay Jain9, 1Clinical Immunology and Rheumatology Services, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, 2Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, 3PGIMER, cHANDIGARH, India, 4Department of Nephrology,, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 5Department of Medical Microbiology,, PGIMER,, Chandigarh, India, 6Internal Medicine (Rheumatology Unit), Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, 7Postgraduate Institute of Medical Education and Research, Chandigarh, India, 8Department of Immunopathology,, PGIMER,, Chandigarh, India, 9Postgraduate Institute of Medical Education and Research, Chandigarh, India, CHANDIGARH, India

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: classification criteria and vasculitis, Wegener's granulomatosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Vasculitis – ANCA-Associated Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: A draft classification criteria of GPA was proposed at ACR meeting in San Diego in 2017. The present criteria is a modification of ACR/EULAR provisional 2017 classification criteria for GPA presented at ACR Washington meeting in 2016. This has been a result of data driven DCVAS study.The purpose of the present study was to validate the recently proposed draft classification criteria of GPA in a real life cohort of ANCA associated vasculitis (AAV).

Methods:

The draft GPA criteria was applied to patients diagnosed to have AAV according to European Medicines Agency (EMA) algorithm. The level of agreement between the draft GPA criteria and EMA algorithm was assessed using Cohen’s kappa. The level of agreement between the ACR/EULAR provisional 2017 classification criteria for GPA and EMA algorithm was also assessed using Cohen’s kappa. Sensitivity and specificity of the draft GPA criteria and the ACR/EULAR provisional 2017 classification criteria for GPA was calculated taking EMA algorithm as gold standard.

Results: 224 patients with mean age of 41.7±15.0 years were included. Female: male ratio was 1.3:1. ANCA by IIF was done in all patients and was positive in 171(cANCA -125, pANCA -46). PR3/MPO ELISA was available in 125 patients (PR3-93, MPO- 32).Using EMA algorithm EGPA was diagnosed in 6, GPA in 187 and MPA in 31. With ACR 1990 criteria, GPA was diagnosed in 137 patients while with draft GPA criteria 136 were classified as GPA. Draft GPA criteria had fair agreement with EMA (kappa-0.23, sensitivity-66%% and specificity-70%) than ACR criteria(kappa 0.1, sensitivity -64% and specificity-45%).ACR/EULAR provisional 2017 classification criteria for GPA also had a fair agreement with EMA(kappa 0.26,sensitivity -69.5% and specificity-70.2%).Eleven of thirty one MPA patients were reclassified as GPA by draft GPA criteria. 5 patients who were classified as GPA by EMA and ACR/EULAR provisional 2017 classification criteria for GPA were excluded by the new criteria. All of them were MPO positive and had pulmonary nodules and paranasal sinus involvement.

Conclusion: Within the limits of a retrospective design, the study showed fair agreement of draft GPA criteria with EMA algorithm. The specificity of the new criteria compared to EMA algorithm is low, likely due to the stress given to PR3/cANCA positivity.

Table 1. Reclassification of various AAV patients (EMA and ACR 1990) by draft GPA criteria

ANCA associated vasculitis

No. of patients (n=224, %,)

Reclassified as GPA by ACR/EULAR 2018 criteria

ACR 1990 GPA

137(61.1)

89

EMA GPA

187(83.4)

125

EMA MPA

31(13.8)

11

EMA EGPA

6(2.6)

0


Disclosure: A. Sharma, None; A. MB, None; G. Naidu, None; M. Rathi, None; K. Sharma, None; V. Dhir, None; R. Nada, None; R. Minz, None; S. Jain, None.

To cite this abstract in AMA style:

Sharma A, MB A, Naidu G, Rathi M, Sharma K, Dhir V, Nada R, Minz R, Jain S. Validation of the Draft Classification Criteria of Granulomatosis with Polyangiitis (GPA) Amongst Indian Patients with ANCA Associated Vasculitis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/validation-of-the-draft-classification-criteria-of-granulomatosis-with-polyangiitis-gpa-amongst-indian-patients-with-anca-associated-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validation-of-the-draft-classification-criteria-of-granulomatosis-with-polyangiitis-gpa-amongst-indian-patients-with-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology